Family-based wellness coaching to prevent type 2 diabetes in Peel
Official title: Peel Family Diabetes Prevention Program (Peel FDPP): Family-Centred Health and Wellness Coaching Pilot Randomized Controlled Trial
Run by Trillium Health Partners · NCT07675551 · Data updated 2026-11-12
A family-focused wellness coaching program is being tested to see if it can reduce diabetes risk for South Asian and Black African/Caribbean families in Peel, Ontario.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 14 Years and up |
| Sex | All |
| Enrollment | 140 (estimated) |
| Sponsor | Trillium Health Partners Academic / other |
| Locations | 2 sites (Brampton, Ontario and 1 other locations) |
| Status | Recruiting |
| Started | May 20, 2026 |
| Main results expected | March 31, 2027 |
| Study ends | September 30, 2027 |
| Registry record updated | October 2, 2026 |
| Trial ID | NCT07675551 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are self-identified South Asian or Black African/Caribbean adult caregivers (18+) in Peel with children under 25 living in the same home, without diabetes or prediabetes requiring treatment.
✕Probably not a fit
Individuals with existing diabetes or prediabetes requiring medical or pharmacologic treatment may not benefit from the intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot randomized trial tests a community-based health coaching intervention delivered to primary family caregivers and optional youth living in the same household, with the aim of reducing type 2 diabetes risk and improving related health outcomes. The study uses a Hybrid Type 2 design to examine both effectiveness and implementation in real-world community settings. Participants are recruited through Peel-based organizations and followed for six months after randomization, with mixed-methods data to inform future scaling and adaptation. The intervention consists of family dyad health and wellness coaching sessions and educational materials, with outcomes including biomarkers, anthropometrics, well-being, knowledge, health behaviors, and family-level effects. The trial targets 70 South Asian and 70 Black African/Caribbean caregiver participants, with optional youth involvement.
Why it matters
Potential benefit: If successful, participants may experience lower diabetes risk and improved health behaviors, with scalable family-centered strategies for diabetes prevention.
How similar studies have gone: Previous community-based diabetes prevention efforts with culturally tailored, family-focused approaches have shown promise, though this specific Hybrid Type 2 pilot in Peel is exploratory.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Study participants will consist of a self-identified primary family caregiver aged 18 years or older with children under 25 year of age living in the same household. Optional youth family member aged 14 to 25 years at the time of study entry are welcome but not mandatory. The primary family caregiver will serve as the primary (index) research participant for the study and should have the following inclusion criteria: 1. Self-identifies as either South Asian or Black, African and Caribbean. 2. Lives in the Peel Region (Mississauga, Brampton or Caledon), Ontario, Canada. 3. Be 18 years or older and have children aged 25 years or under in the same household. AND 4. Have no medical diagnosis (self-reported) of diabetes. 5. Have no medical diagnosis (self-reported) of prediabetes that requires any medical or pharmacological treatment. Have a blood-based sugar lower than or equal to 6.5 measured through the hemoglobin A1c test using a finger prick at the pre-enrollment assessment visit. AND 6. The family caregiver and optional youth (when participating) must be proficient in English (reading, writing, and speaking), as English will be the primary language used for the participation eligibility, implementation, delivery, and evaluation of the intervention. Exclusion Criteria for family dyad: 1. Do not meet all the criteria above. 2. A medical condition or health professional has advised them not to engage in physical activity of any type, or they are following a specific diet. 3. Cannot give informed consent to participate voluntarily in the intervention and study.
Where it's running
-
Wellfort Community Health Services
Brampton, Ontario, Canada Recruiting -
Punjabi Community Health Services (PCHS)
Brampton, Ontario, Canada Recruiting
Study contacts
- Principal investigator: Ian Zenlea, MD, MPH — Institute for Better Health, Trillium Health Partners, Mississauga.
- Study coordinator: Cilia Mejia-Lancheros (Study Research Lead), RN, MPH, Msc. GHP, PhD
- Email: Cilia.Mejia-Lancheros@thp.ca
- Phone: 437 216 6209
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Occupation-based lifestyle program for adults with type 2 diabetes
A online program tests whether an occupation-focused lifestyle plan helps adults with type 2 diabetes manage daily routines and feel better in life.
-
Downhill walking training for type 2 diabetes
Researchers compare 8 weeks of downhill walking to level-ground walking in adults with type 2 diabetes to see which more improves walking ability and muscle and heart responses.
-
Normast 3 for adults with diabetic polyneuropathy
A 12-week trial will test whether Normast 3 helps reduce nerve pain in adults with diabetic polyneuropathy compared with a placebo.
-
Remote exercise program to improve blood sugar control and fitness in adults with type 2 diabetes
A remote 12‑week exercise program plus health education is tested in adults with type 2 diabetes to see if it improves blood sugar control and physical fitness.
-
Semaglutide Depot in Type 2 Diabetes: Safety, Tolerability, and How It Works
This study tests a long-acting form of semaglutide given every four weeks to adults with type 2 diabetes to see if it is safe and helps control blood sugar and weight.
-
Endothelial progenitor cell dysfunction and inflammation in heart and blood vessel problems of type 2 diabetes
This project will test whether endothelial progenitor cells from adults with type 2 diabetes — with or without cardiovascular complications — have signaling and inflammation-related defects and whether boosting eNOS in those cells improves their repair function.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.